Magda L Atilano
Overview
Explore the profile of Magda L Atilano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giblin A, Cammack A, Blomberg N, Anoar S, Mikheenko A, Carcole M, et al.
Nat Neurosci
. 2025 Mar;
PMID: 40055545
No abstract available.
2.
Giblin A, Cammack A, Blomberg N, Anoar S, Mikheenko A, Carcole M, et al.
Nat Neurosci
. 2025 Feb;
PMID: 40000803
Here we report a conserved transcriptomic signature of reduced fatty acid and lipid metabolism gene expression in a Drosophila model of C9orf72 repeat expansion, the most common genetic cause of...
3.
Hull A, Atilano M, Hallqvist J, Heywood W, Kinghorn K
Hum Mol Genet
. 2024 Oct;
33(24):2111-2122.
PMID: 39402882
Types A and B Niemann-Pick disease (NPD) are inherited multisystem lysosomal storage disorders due to mutations in the SMPD1 gene. Respiratory dysfunction is a key hallmark of NPD, yet the...
4.
Hull A, Atilano M, Gergi L, Kinghorn K
Philos Trans R Soc Lond B Biol Sci
. 2024 Feb;
379(1899):20220381.
PMID: 38368939
Impairment of autophagic-lysosomal pathways is increasingly being implicated in Parkinson's disease (PD). mutations cause the lysosomal storage disorder Gaucher disease (GD) and are the commonest known genetic risk factor for...
5.
Urena E, Xu B, Regan J, Atilano M, Minkley L, Filer D, et al.
Proc Natl Acad Sci U S A
. 2024 Jan;
121(4):e2311313121.
PMID: 38241436
Pharmacological therapies are promising interventions to slow down aging and reduce multimorbidity in the elderly. Studies in animal models are the first step toward translation of candidate molecules into human...
6.
Atilano M, Hull A, Romila C, Adams M, Wildfire J, Urena E, et al.
PLoS Genet
. 2023 Dec;
19(12):e1011063.
PMID: 38127816
Mutations in the GBA1 gene cause the lysosomal storage disorder Gaucher disease (GD) and are the greatest known genetic risk factors for Parkinson's disease (PD). Communication between the gut and...
7.
Catterson J, Minkley L, Aspe S, Judd-Mole S, Moura S, Dyson M, et al.
Neurobiol Aging
. 2023 Oct;
132:154-174.
PMID: 37837732
Amyloid β (Aβ) accumulation is a hallmark of Alzheimer's disease. In adult Drosophila brains, human Aβ overexpression harms climbing and lifespan. It's uncertain whether Aβ is intrinsically toxic or activates...
8.
Xu D, Vincent A, Gonzalez-Gutierrez A, Aleyakpo B, Anoar S, Giblin A, et al.
PLoS Genet
. 2023 Sep;
19(9):e1010893.
PMID: 37733679
Brains are highly metabolically active organs, consuming 20% of a person's energy at resting state. A decline in glucose metabolism is a common feature across a number of neurodegenerative diseases....
9.
Atilano M, Gronke S, Niccoli T, Kempthorne L, Hahn O, Moron-Oset J, et al.
Elife
. 2021 Mar;
10.
PMID: 33739284
G4C2 repeat expansions within the gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The repeats undergo repeat-associated non-ATG translation to generate toxic...
10.
Moens T, Niccoli T, Wilson K, Atilano M, Birsa N, Gittings L, et al.
Acta Neuropathol
. 2019 Jan;
137(3):487-500.
PMID: 30604225
A GGGGCC hexanucleotide repeat expansion within the C9orf72 gene is the most common genetic cause of both amyotrophic lateral sclerosis and frontotemporal dementia. Sense and antisense repeat-containing transcripts undergo repeat-associated...